<code id='FA9B50E1A7'></code><style id='FA9B50E1A7'></style>
    • <acronym id='FA9B50E1A7'></acronym>
      <center id='FA9B50E1A7'><center id='FA9B50E1A7'><tfoot id='FA9B50E1A7'></tfoot></center><abbr id='FA9B50E1A7'><dir id='FA9B50E1A7'><tfoot id='FA9B50E1A7'></tfoot><noframes id='FA9B50E1A7'>

    • <optgroup id='FA9B50E1A7'><strike id='FA9B50E1A7'><sup id='FA9B50E1A7'></sup></strike><code id='FA9B50E1A7'></code></optgroup>
        1. <b id='FA9B50E1A7'><label id='FA9B50E1A7'><select id='FA9B50E1A7'><dt id='FA9B50E1A7'><span id='FA9B50E1A7'></span></dt></select></label></b><u id='FA9B50E1A7'></u>
          <i id='FA9B50E1A7'><strike id='FA9B50E1A7'><tt id='FA9B50E1A7'><pre id='FA9B50E1A7'></pre></tt></strike></i>

          Home / fashion / hotspot

          hotspot


          hotspot

          author:entertainment    Page View:339
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In